SecBot SecBot
8-K ·Filed Apr 29, 2026

FMC

FMC CORP
MIXED
Impact 5/10
Horizonweeks Processed6mo ago SEC0000037785-26-000083
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

The Q1 beat and maintained guidance provide near-term relief, but the underlying business continues to shrink (revenue -4%, EBITDA -40%). Monitor any updates from the strategic review as the primary catalyst. Q2 guidance implies further deterioration, so expect volatility around guidance execution.

DirectionMixed
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$15.38
T+0 close · Apr 29, 2026 · via day close
Latest settled
−27.70%
T+60 · $11.12
Vs SPY
−30.81%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 30 $15.38entry
  2. T+1 · 7mo ago 0.00%α −0.22% · $15.38
  3. T+5 · 6mo ago −3.84%α −5.56% · $14.79
  4. T+20 · 6mo ago −11.77%α −16.74% · $13.57
  5. T+60 · 4mo ago −27.70%α −30.81% · $11.12
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

FMC reported Q1 2026 adjusted loss per share of -$0.23, beating consensus of -$0.38, on revenue of $762M (ex-India) vs $742.4M estimate. The company reaffirmed its full-year 2026 guidance, which implies continued revenue and EBITDA declines. The strategic review announced in February 2026 remains ongoing.

Key Financial Metrics

EPS
−$0.23
est −$0.38 · +39.5%
Revenue
$762.0M
est $742.4M · +2.6% · -4.0% YoY
Rating
beat
Guidance
$3.60B-$3.80B
maintained
Free Cash Flow
-$628.1M

Key Facts

  • Q1 2026 adjusted loss per share -$0.23 vs consensus -$0.38 (beat by $0.15)
  • Q1 2026 revenue ex-India $762M, down 4% YoY, above $742.4M consensus
  • Full-year 2026 guidance maintained: revenue $3.6B-$3.8B, adjusted EBITDA $670M-$730M, adjusted EPS $1.63-$1.89
  • Q2 2026 outlook: revenue $850M-$900M, adjusted EPS $0.16-$0.26 (down ~70% YoY at midpoint)
  • Strategic review including potential sale of the company is progressing
  • Adjusted EBITDA of $72M was down 40% YoY and above the high end of guidance range

Financial Impact

Adjusted EPS beat of $0.15 vs consensus (-$0.23 vs -$0.38), revenue beat of ~$20M vs consensus, but both down YoY

revenueadjustedEpsadjustedEbitda

Risk Factors

  • Continued revenue and EBITDA declines in 2026
  • Uncertainty regarding the strategic review outcome (potential sale at unfavorable terms)
  • High debt load ($4.5B total debt) and negative free cash flow
  • Post-patent erosion of Rynaxypyr franchise

Market Snapshot

Exchange
NYSE
Sector
Chemicals & Allied Products
Analyst Consensus
33% bullish (24 analysts)

Investment Themes

Materials & Mining

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000037785-26-000083
Document: fmc-20260429.htm0000037785-26-000083
Document: 0000037785-26-000083-index-headers.html0000037785-26-000083
Document: 0000037785-26-000083-index.html0000037785-26-000083
Document: 0000037785-26-000083.txt0000037785-26-000083
8-K Data (Synthetic)0000037785-26-000083

Track record

25 reports on FMC

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +27.91% at T+60 after the Apr 20, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $5.06 Now $5.23 +3.36% settles Nov 19
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $5.64 Now $5.23 −7.27% settles Nov 17
  3. Nov 4, 202612d ago Institutional Cluster Mixed 3/10 Entry $6.42 to $5.65 Now $5.23 −18.54% ▼ −11.99% −11.08% vs SPY
  4. Nov 3, 202613d ago 144 Neutral 2/10 Entry $6.09 to $5.64 Now $5.23 −14.12% ▼ −7.39% −6.80% vs SPY
  5. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $6.20 to $5.63 Now $5.23 −15.65% ▼ −9.19% −6.49% vs SPY
  6. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $6.20 to $5.63 Now $5.23 −15.65% ▼ −9.19% −6.49% vs SPY
  7. Oct 29, 202618d ago 8-K Bearish 7/10 Entry $6.20 to $5.63 Now $5.23 +15.65% ▲ +9.19% +6.49% vs SPY
  8. Oct 27, 202620d ago SC 13G/A Neutral 4/10 Entry $4.47 to $6.42 Now $5.23 +17.00% ▲ +43.62% +44.34% vs SPY
  9. Oct 21, 202626d ago 8-K Neutral 2/10 Entry $5.02 to $4.75 Now $5.23 +4.18% ▼ −5.38% −6.09% vs SPY
  10. Oct 21, 202626d ago 8-K Neutral 3/10 Entry $5.02 to $4.75 Now $5.23 +4.18% ▼ −5.38% −6.09% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens Wed (11h 33m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 29, 2026